West Pharma (WST) Tops Q3 EPS by 6c, Revenues Beat; Reaffirms FY18 EPS Mid-Point Guidance Above Consensus, Offers FY18 Revenue Outlook
Go back to West Pharma (WST) Tops Q3 EPS by 6c, Revenues Beat; Reaffirms FY18 EPS Mid-Point Guidance Above Consensus, Offers FY18 Revenue Outlook| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 361.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $361.78 | 52 Week High | $84.33 | |||
| Open | $361.78 | 52 Week Low | $53.88 | |||
| Day High | $361.78 | P/E | 230.43 | |||
| Day Low | $361.78 | EPS | $1.57 | |||
| Volume | 2,053 | |||||
